Karyopharm Therapeutics (KPTI) Raw Materials (2019 - 2026)
Karyopharm Therapeutics (KPTI) reported Raw Materials of $628,000 for Q2 2026, up 31.7% from $477,000 a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Raw Materials (2019 - 2026) Analysis & Trends
Dating back to Q4 2019, Karyopharm Therapeutics' Raw Materials record includes 25 quarters.
- Raw Materials has a five-year compound annual growth rate of -20.0% (FY2020 to FY2025).
- By year, Raw Materials came in at $720,000 in FY2024 (+30.2%), $553,000 in FY2023 (-59.6%), $1.37 million in FY2022 (-23.8%) and $1.8 million in FY2021 (-6.4%).
- Five-year quarterly Raw Materials spans a low of $261,000 in Q2 2022 and a high of $2.56 million in Q1 2022.
- Year over year, Raw Materials gained in three of the last seven quarters, with growth averaging 11.2%.
- The high point for year-over-year Raw Materials in five years was Q2 2023 (growth of 330.7%); the low point was Q2 2022 (a decline of 85.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Karyopharm Therapeutics | 12.16 Mn | -214.27 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 628,000.00 |
| Dec 31, 2025 | 628,000.00 |
| Sep 30, 2025 | 630,000.00 |
| Jun 30, 2025 | 477,000.00 |
| Mar 31, 2025 | 508,000.00 |
| Dec 31, 2024 | 720,000.00 |
| Sep 30, 2024 | 720,000.00 |
| Jun 30, 2024 | 723,000.00 |
| Mar 31, 2024 | 553,000.00 |
| Dec 31, 2023 | 553,000.00 |
| Sep 30, 2023 | 391,000.00 |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 262,000.00 |
| Jun 30, 2022 | 261,000.00 |
| Mar 31, 2022 | 2.56 Mn |
| Dec 31, 2021 | 1.80 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 1.83 Mn |
API Access
Karyopharm Therapeutics Raw Materials API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=raw-materials&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "raw-materials", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=raw-materials&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();